Pulmonary Disease, Chronic Obstructive

11 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Lung Diseases

Treatments and conditions

Pulmonary Disease, Chronic Obstructive
Treatment and conditionWhere it standsTrials
Air cleaner for pulmonary disease, chronic obstructivePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Benralizumab for pulmonary disease, chronic obstructivePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
clonal fetal MSCs for pulmonary disease, chronic obstructiveTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CM326 dose 1 + CM326 dose 2 for pulmonary disease, chronic obstructivePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Depemokimab for pulmonary disease, chronic obstructivePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Quality-of-Life Assessment + Questionnaire Administration + Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine for pulmonary disease, chronic obstructivePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for pulmonary disease, chronic obstructivePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sildenafil Citrate for pulmonary disease, chronic obstructivePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tozorakimab for pulmonary disease, chronic obstructivePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
TQC2731 injection for pulmonary disease, chronic obstructivePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Treprostinil for pulmonary disease, chronic obstructiveTrial registered, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.